Celltrion wins conditional nod for Regkirona in Switzerland

14 January 2022 - Celltrion said that Swiss Medic, Switzerland’s drug administration, has temporary authorisation for Regkirona (regdanvimab). ...

Read more →

Swiss regulator approves Roche-Regeneron COVID-19 drug

27 December 2021 - The Swiss medicines agency, Swissmedic, has given the green light to the monoclonal antibody cocktail Ronapreve developed ...

Read more →

Janssen COVID-19 booster shot approved in Switzerland

28 December 2021 - Medicines regulator Swissmedic has approved the booster of the single-dose vaccine from Johnson & Johnson. ...

Read more →

Pfizer/BioNTech vaccine approved for children by Swiss regulator

10 December 2021 - The Swiss medical regulator has approved the use of Pfizer/BioNTech’s Covid-19 vaccine for children aged five to ...

Read more →

Swiss regulator approves Pfizer/BioNTech booster for 16 and up

23 November 2021 - Swissmedic has approved the extension of COVID-19 boosters for the Pfizer/BioNTech vaccine to all people aged 16 ...

Read more →

EffRx obtains Swiss marketing authorization for Bronchitol in cystic fibrosis

4 November 2021 - EffRx Pharmaceuticals today announced that Swissmedic has approved Bronchitol (inhaled mannitol) for the treatment of cystic fibrosis ...

Read more →

AstraZeneca pulls request for Swiss approval of COVID shot

5 November 2021 - AstraZeneca says it is withdrawing its application for approval of its COVID-19 vaccine in Switzerland because the ...

Read more →

Moderna announces Swissmedic authorises booster dose of Moderna’s COVID-19 vaccine

26 October 2021 - Authorisation granted for particularly vulnerable individuals 12 years of age and older. ...

Read more →

Deciphera announces approval of Qinlock in Switzerland for the treatment of fourth-line gastro-intestinal stromal tumour

12 October 2021 - Seventh approval worldwide for Qinlock and first European approval. ...

Read more →

BioCryst announces acceptance of regulatory applications for Orladeyo (berotralstat) by Health Canada and Swissmedic

25 August 2021 - BioCryst Pharmaceuticals today announced that the new drug submission for Orladeyo (berotralstat) has been accepted for ...

Read more →

Clovis Oncology announces availability of and reimbursement for Rubraca (rucaparib) tablets for women with relapsed ovarian cancer in Switzerland

24 August 2021 - Rubraca is commercially available in Germany, United Kingdom, Italy, Spain, France, Netherlands, United States of America and ...

Read more →

Moderna COVID-19 vaccine gets Swiss approval for 12 to 17 year-olds

9 August 2021 - Swissmedic has approved the Moderna COVID-19 vaccine for 12- to 17-year-olds, the Swiss agency said on ...

Read more →

Australia-Canada-Singapore-Switzerland-United Kingdom (Access) Consortium

22 June 2021 - The TGA is a member of the Access consortium along with Health Canada, Health Sciences Authority of ...

Read more →

Emmaus Life Sciences announces submission of marketing authorisation application to Swissmedic; Ideogen to manage early access program

15 June 2021 - Emmaus Life Sciences anounced today it has received confirmation from the Swiss Agency for Therapeutic Products ...

Read more →

Moderna seeks vaccine approval for adolescents

11 June 2021 - US-based biotech company Moderna is applying for the use of its COVID-19 vaccine for adolescents aged 12 ...

Read more →